InLine-Med
Magdeburg
About InLine-Med
InLine-Med GmbH brings a solution that combines artificial intelligence, the most innovative guiding tools and high-quality biopsy needles to improve efficiency, accuracy and safety in cancer diagnosis and treatment. Within these procedures an accurate needle placement is essential, which is still a challenging task due to space limitations and a lack of easy to integrate assistance devices. By using artificial intelligence algorithms, our solution translates the planning of the clinician from the computer viewer to the patient without the need of expensive and complicated robotic systems. Once the clinician defines a needle trajectory, the app will indicate where to place the sterilized-disposable needle-guide to fulfill his planning. Hence, less punctures are needed, the procedure time is reduced and risk for patient and clinician is reduced. The complete solution of assistance tools and biopsy needle can be acquired at a price similar to normal biopsy needles in the market and enables clinicians to perform safe, precise, intuitive and efficient cancer diagnosis and treatment.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jul 2022)
- Website: inline-med.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), GPS, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/inline-med-2633020 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.